| 
                        1.
                     | 
                        Nevanac
                     | 
                        Susp Opht 1 mg/ml
                     | 
                        5 ml
                     | 
                        12.73
                     | 
                        30.25
                     | 
                        01.12.2022
                     | 
                                                
                     | 
                        
                     | 
                      
                     | 
                        Nein                        
                     | 
                        58745001
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Nepafenacum
                     | 
                        18966
                     | 
                        01.02.2009
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                         
                     | 
                        11.06.30.
                     | 
                        S01BC10
                     | 
					
						| 
                        2.
                     | 
                        Nevanac
                     | 
                        Susp Opht 3 mg/ml 
                     | 
                        Fl 3 ml
                     | 
                        12.73
                     | 
                        30.25
                     | 
                        01.12.2022
                     | 
                                                
                     | 
                        
                     | 
                      
                     | 
                        Nein                        
                     | 
                        65711001
                     | 
                        Novartis Pharma Schweiz AG
                     | 
                        Nepafenacum
                     | 
                        20761
                     | 
                        01.05.2018
                     | 
                        
                                                            
                                    
                                
                     | 
                        
                     | 
                        
                     | 
                         
                     | 
                        11.06.30.
                     | 
                        S01BC10
                     |